ARYLCHINAZOLINE

European patent · EP2994467 · In force

Register entry

Publication number
EP2994467
Application number
EP14726074
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 8, 2014
Published
Mar 16, 2016
Granted
Aug 1, 2018
Protection ends at the latest
May 7, 2034
Next annual fee due
May 31, 2027
IPC classes
C07D 405/14 (2006.01)
C07D 401/10 (2006.01)
C07D 403/10 (2006.01)
C07D 405/04 (2006.01)
C07D 417/10 (2006.01)
C07D 417/14 (2006.01)
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
C07D 491/048 (2006.01)
C07D 495/04 (2006.01)
C07D 498/08 (2006.01)
C07D 513/04 (2006.01)
A61K 31/506 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Priority
DE 102013008118 11.05.2013
PCT application
PCT/EP2014/001236 08.05.2014
PCT publication
WO2014/183850 20.11.2014
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Aug 1, 2018

    Granted

    Published in Swissreg on 01.08.2018

Parties

Inventor

FUCHSS, Thomas

64625 Bensheim-Auerbach, DE

EMDE, Ulrich

64291 Darmstadt, DE

BUCHSTALLER, Hans-Peter

64347 Griesheim, DE

MEDERSKI, Werner

64673 Zwingenberg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.